Literature DB >> 10394590

Leukemia in infants.

C A Felix1, B J Lange.   

Abstract

Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in infants have in common a high incidence of translocations of the MLL gene at chromosome band 11q23. Similar translocations occur in leukemias associated with chemotherapies that target DNA topoisomerase II. MLL has numerous different partner genes. The role of the many MLL fusion proteins in leukemogenesis is not yet understood. The t(4;11) translocation, the most common translocation in infant ALL, adversely affects the outcome. Additional genetic changes, especially Ikaros alterations, are found in infant ALL. Other forms of myeloid leukemia in infants present as myelodysplastic and myeloproliferative syndromes, which may be associated with constitutional disorders. This review will consider all leukemia in infants, but will focus on leukemias with MLL gene translocations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394590

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  16 in total

1.  Parental Age and Risk of Infant Leukaemia: A Pooled Analysis.

Authors:  Erin L Marcotte; Todd E Druley; Kimberly J Johnson; Michaela Richardson; Julie von Behren; Beth A Mueller; Susan Carozza; Colleen McLaughlin; Eric J Chow; Peggy Reynolds; Logan G Spector
Journal:  Paediatr Perinat Epidemiol       Date:  2017-09-22       Impact factor: 3.980

2.  Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group.

Authors:  Erin L Marcotte; Michaela R Richardson; Michelle A Roesler; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-22       Impact factor: 4.254

3.  Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.

Authors:  M D Megonigal; E F Rappaport; R B Wilson; D H Jones; J A Whitlock; J A Ortega; D J Slater; P C Nowell; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

4.  Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations.

Authors:  Shinichiro Nakada; Yoko Katsuki; Issei Imoto; Tetsuji Yokoyama; Masayuki Nagasawa; Johji Inazawa; Shuki Mizutani
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

5.  Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.

Authors:  Jean E Sanders; Ho Joon Im; Paul A Hoffmeister; Ted A Gooley; Ann E Woolfrey; Paul A Carpenter; Robert G Andrews; Eileen M Bryant; Frederick R Appelbaum
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

6.  Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia.

Authors:  Anna M Azarova; Ren-Kuo Lin; Yuan-Chin Tsai; Leroy F Liu; Chao-Po Lin; Yi Lisa Lyu
Journal:  Biochem Biophys Res Commun       Date:  2010-07-16       Impact factor: 3.575

7.  Estrogen treatment induces MLL aberrations in human lymphoblastoid cells.

Authors:  Sabine Schnyder; Nga T Du; Hongan B Le; Sheetal Singh; Grace A Loredo; Andrew T Vaughan
Journal:  Leuk Res       Date:  2009-03-05       Impact factor: 3.156

Review 8.  Topoisomerase II and leukemia.

Authors:  Maryjean Pendleton; R Hunter Lindsey; Carolyn A Felix; David Grimwade; Neil Osheroff
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691

Review 9.  DNA topoisomerase II, genotoxicity, and cancer.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Mutat Res       Date:  2007-07-03       Impact factor: 2.433

10.  Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha.

Authors:  Joseph E Deweese; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2008-03-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.